Skip to main content
# Title Department Research Year
411 Evaluation of autophagy-related genes in Egyptian systemic
lupus erythematosus patients
2020
412 Further Insight Into the Dual COX-2 and 15-LOX Anti-Inflammatory Activity of 1,3,4-Thiadiazole-thiazolidinone Hybrids: The Contribution of the Substituents at 5th Positions is Size Dependent Department of Pharmaceutical Organic Chemistry 2020
413 Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders 2020
414 Latanoprost niosomes as a sustained release ocular delivery system for the
management of glaucoma
Department of Pharmaceutics 2020
415 Synthesis of some new 1,2-disubstituted-1,2,4-triazolobenzimidazoles with antifungal and anti-inflammatory effects. Department of Pharmaceutical Organic Chemistry 2020
416 Epigallocatechin-3-Gallate-Loaded Gold
Nanoparticles: Preparation and Evaluation of
Anticancer Efficacy in Ehrlich Tumor-Bearing Mice
Department of Pharmaceutics 2020
417 Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19 Department of Pharmaceutics 2020
418 Design and synthesis of some 1,3,5-tri-substituted oxindole derivatives as potential CDK inhibitors Department of Medicinal Chemistry 2020
419 Antimicrobial Pyridazines: Synthesis, Characterization, Cytotoxicity, Substrate Promiscuity, and Molecular Docking Department of Pharmaceutical Organic Chemistry 2020
420 Severe cutaneous adverse drug reactions: Incidence, Clinical Patterns, Causative Drugs and Modalities of Treatment in Assiut University Hospital, Upper Egypt 2020